ANTILEUKOPROTEASE - AN ENDOGENOUS PROTEIN IN THE INNATE MUCOSAL DEFENSE AGAINST FUNGI

Citation
Jfc. Tomee et al., ANTILEUKOPROTEASE - AN ENDOGENOUS PROTEIN IN THE INNATE MUCOSAL DEFENSE AGAINST FUNGI, The Journal of infectious diseases, 176(3), 1997, pp. 740-747
Citations number
54
Categorie Soggetti
Infectious Diseases
ISSN journal
00221899
Volume
176
Issue
3
Year of publication
1997
Pages
740 - 747
Database
ISI
SICI code
0022-1899(1997)176:3<740:A-AEPI>2.0.ZU;2-N
Abstract
Previous studies have suggested that endogenous protease inhibitors ma y participate in the mucosal host defense. Antileukoprotease (ALP) is an important protease inhibitor found on various mucosal surfaces, inc luding those of the respiratory and genital tracts. This study reports on the antimicrobial activity of recombinant (r) ALP toward the human fungal pathogens Aspergillus fumigatus and Candida albicans. rALP exp ressed pronounced fungicidal activity toward metabolically active A. f umigatus conidia and C. albicans yeast cells; however, metabolically q uiescent A. fumigatus conidia were totally resistant. In contrast with the protease inhibitory activity of rALP, the fungicidal activity was localized primarily in the NH2-terminal domain. On a molar base, the fungicidal activity of rALP was comparable with that of human defensin s and lysozyme. In addition, rALP caused inhibition of C. albicans yea st cell growth. By exhibiting antifungal activity, ALP may play an imp ortant role in the innate mucosal defense against human pathogenic fun gi.